SCHEMBL25919345

SCHEMBL25919345

CCCCC1=NCc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.43
▸ ADRA2A P08913 3/20 0.37
▸ ADRA2B P18089 3/20 0.37
▸ ADRA2C P18825 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11124045 0.88 TSHR (0.40) TSHRADRA2AADRA2BADRA2CALDH1A1
SCHEMBL27577140 0.83 KDM4E (0.53) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL11923501 0.83 TSHR (0.50) TSHRADRA2AADRA2BADRA2CALDH1A1
SCHEMBL29868676 0.78 KDM4E (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7759078 0.78 KDM4E (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL11922776 0.78 HRH4 (0.41) TSHRADRA2AADRA2BADRA2CCYP1A2
SCHEMBL4764699 0.77 MEN1 (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL27996594 0.77 MEN1 (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL14507195 0.73 HRH4 (0.46) SIGMAR1
SCHEMBL22431952 0.73 TSHR (0.48) TSHRADRA2AADRA2BADRA2CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023132606-A1 NOVEL ISOINDOLINONE DERIVATIVE COMPOUNDS AS CASPASE INHIBITORS 주식회사 이노보테라퓨틱스 2023-07-13 — — WO disclosed
Send feedback